Isotiorga

Isotretinoin, the active ingredient in Isotiorga, is a retinoid presented as an oral formulation for oral use. It treats severe nodular acne and acne vulgaris in patients who have not responded to conventional therapy.

GNH USA supplies Isotiorga as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isotiorga is a retinoid indicated for severe forms of acne that are refractory to standard therapy. - Severe nodular acne: markedly reduces inflammatory nodules and prevents new lesion formation. - Acne vulgaris: decreases comedones and inflammatory papules in moderate to severe cases. - Acne conglobata: helps control extensive nodular and cystic lesions when other treatments have failed.

Isotiorga may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Dry skin and mucous membranes - Cheilitis (cracked lips) - Nasal dryness and epistaxis - Photosensitivity - Elevated liver enzymes - Hypertriglyceridemia

Serious or Rare Side Effects: - Severe depression or mood changes - Inflammatory bowel disease - Pancreatitis - Severe hypercalcemia - Teratogenic effects (birth defects) - Visual disturbances such as night blindness

Isotiorga requires careful monitoring and specific safety measures before and during therapy. - Pregnancy: contraindicated; isotretinoin is category X and must not be used by pregnant women. - Liver function: obtain baseline and periodic liver enzyme tests. - Lipid profile: monitor triglycerides and cholesterol regularly. - Vitamin A supplementation: avoid concurrent use to prevent excess toxicity. - Contraception: ensure effective birth control for both sexes throughout treatment and for one month after discontinuation. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Isotiorga can interact with several medicines, altering efficacy or increasing toxicity.

Major Interactions (Avoid): - Tetracyclines: increased risk of intracranial hypertension. - Vitamin A supplements: additive retinoid toxicity. - Systemic corticosteroids: may reduce isotretinoin effectiveness.

Moderate Interactions (Monitor Closely): - Ketoconazole and other azole antifungals: may raise isotretinoin plasma levels. - Phenytoin and other enzyme inducers: may lower isotretinoin concentrations. - Oral contraceptives: monitor for reduced contraceptive reliability. - Other retinoids (e.g., bexarotene): risk of cumulative adverse effects.